# Final Readiness Report — MECA Package Generation Engine

Consolidates: `REVERSE_ENGINEERING_REPORT.md`, `FUNCTIONAL_SPECIFICATION.md`, `01_BUSINESS_RULE_BOOK.md`, `02_ARCHITECTURE_DECISION_RECORDS.md`, `03_TEST_SPECIFICATION.md`, `04_PRODUCT_BACKLOG.md`, `05_SYSTEM_MODULE_BREAKDOWN.md`, `06_DATA_FLOW_DOCUMENT.md`, `07_RISK_REGISTER.md`, `08_IMPLEMENTATION_ROADMAP.md`.

**No code has been written. No implementation has begun.** This report is the release gate for that decision.

---

## Scorecard

| Metric | Score | Basis |
|---|---|---|
| **Business Rule Coverage** | 100% documented / **67.5% Confirmed** | 160 rules extracted from 3 sample packages; 108 Confirmed (3/3 evidence), 24 Strongly Inferred, 28 Requires Business Confirmation |
| **Functional Specification Coverage** | ~95% | Every field of all 5 output XML types mapped; the ~5% gap is the handful of fields whose *correct* behavior is genuinely unknowable from 3 samples alone (e.g. non-CC-BY license text, 4th+ round behavior) — these are enumerated, not missing |
| **Architecture Completeness** | ~85% | All 16 modules specified with responsibilities/dependencies; data flow fully traced end-to-end; 2 of 31 ADRs are informational-only (no confirmation needed), the remaining 29 are fully drafted with a recommended decision but await sign-off |
| **Test Specification Coverage** | ~90% | 187 test cases across 25 categories, covering every Business Rule Book category plus enterprise-scale concerns (performance, memory, recovery, retry, parallelism, S3 failure) |
| **Implementation Readiness** | **~40%** | Design and documentation are release-ready; actual coding readiness is gated by the 29 unresolved ADRs, several of which (007, 002, 003, 015, 017, 018, 022, 031) block entire Epics from starting cleanly |
| **Overall Product Readiness Score** | **~55%** | Weighted: documentation/design (95% complete) carries less weight toward "product readiness" than business-decision closure and working code (0% started) |

**Reading the gap:** the documentation set is comprehensive and internally consistent; what's missing for implementation readiness is not more analysis — it's business sign-off on already-identified, already-answerable questions.

---

## Outstanding Business Decisions (must be reviewed and approved before implementation begins)

These are the ADRs from `02_ARCHITECTURE_DECISION_RECORDS.md` tagged **Business Confirmation Required: Yes**, ordered by how many downstream Epics they block. **Do not begin Phase 1 of the Implementation Roadmap until at minimum the Critical-priority items below are resolved.**

### Must resolve before any development starts (blocks Foundation/Phase 1 design):
1. **ADR-031** — Should the converter ever replicate a defect found in the hand-built samples, or always generate clean/correct output? *(Resolves the default answer to ADR-010, ADR-011, and every similar question — resolve this one first.)*
2. **ADR-018** — Metadata source strategy: which fields are config/DB-driven vs. file-derived, from day one?
3. **ADR-028** — Is multi-journal/multi-publisher support actually on the roadmap, or is Clinical Science / Portland Press the only journal this product will ever need to process? *(Materially changes Epic 2 and Epic 14 scope.)*

### Must resolve before Epic 4 (article.xml) / Epic 7 (transfer.xml) development:
4. **ADR-007** — Correct `transfer.xml` journal acronym (`"CLINSCI"` vs `"CS"`) — **highest-priority open question in the entire spec.**
5. **ADR-002** — License text for non-CC-BY articles.
6. **ADR-001** — `article-type` mapping for article types beyond Research/Review.
7. **ADR-015** — DOI uniqueness validation scope (per-run / per-journal / global).

### Must resolve before Epic 6 (reviews.xml) development:
8. **ADR-003** — Reviewer PDF attachments: link only, or fetch-and-package?
9. **ADR-005** — Scope of reviews.xml content depth (author-suggested reviewers, editor-reassignment history, copyediting queries).
10. **ADR-004** — Duplicate correspondence entries: always include, de-duplicate, or configurable?

### Must resolve before Epic 6 (Packaging/Recovery) development:
11. **ADR-017** — Package atomicity design confirmation.
12. **ADR-022** — Restartability/checkpointing granularity confirmation.
13. **ADR-023** — Retry policy thresholds (counts/backoff).

### Should resolve before the relevant Epic, lower urgency:
14–29. ADR-006, 008, 009, 010, 011, 012, 013, 014, 016, 019, 020, 024, 025, 026, 027, 029, 030 — see `02_ARCHITECTURE_DECISION_RECORDS.md` for full detail on each; none of these block *starting* development broadly, but each blocks its specific Epic's *completion*.

**Total: 29 of 31 ADRs require explicit sign-off. Recommend a single consolidated decision-review session covering all 29, rather than resolving them piecemeal as each Epic is reached — several answers (especially ADR-031, ADR-018, ADR-028) change the shape of multiple other ADRs' recommended decisions.**

---

## Remaining Risks (top 10, full register in `07_RISK_REGISTER.md`)

1. **RISK-001** — Wrong transfer.xml acronym reaches production undetected.
2. **RISK-002** — License-text legal/compliance exposure.
3. **RISK-004** — ADR backlog stalls development if not resolved on schedule.
4. **RISK-012** — Unicode corruption undetected due to largely-Latin-script sample base.
5. **RISK-016** — Multi-round generalization (3+ rounds) unverified against real data.
6. **RISK-017** — DOI Registry / Checkpoint Store concurrency bugs under real production load.
7. **RISK-018** — Package atomicity gap allowing a partial package to leak into production.
8. **RISK-019** — Restart/checkpoint logic gap causing reprocessing or data loss.
9. **RISK-021** — Memory leak surfacing only late in a full-scale batch run.
10. **RISK-024** — Inconsistent "never replicate a defect" implementation across generators built by different developers.

---

## Recommended Next Step

1. **Convene a single decision-review session** with the business/product stakeholders (Portland Press/Silverchair liaison, Legal, Product Owner) covering all 29 outstanding ADRs, starting with the 3 "must resolve first" items (ADR-031, ADR-018, ADR-028), since their answers reshape several other ADRs.
2. **Record every decision as a formal ADR status change** (PROPOSED → ACCEPTED, with the actual chosen option and date) — do not proceed on a verbal or implied answer.
3. **Re-baseline the Business Rule Book's 28 "Requires Business Confirmation" entries** against the now-resolved ADRs, promoting each to "Confirmed" once its corresponding decision is locked.
4. **Only then** begin `08_IMPLEMENTATION_ROADMAP.md` Phase 1 (Foundation).

**Implementation does not begin until this review is complete and the decisions above are explicitly approved.**
